Logotipo do repositório
 

Publicação:
Infliximab-induced psoriasis during therapy for Crohn's disease

dc.contributor.authorSteinwurz, Flavio
dc.contributor.authorDenadai, Rafael [UNESP]
dc.contributor.authorSaad-Hossne, Rogerio [UNESP]
dc.contributor.authorQueiroz, Maria Luiza
dc.contributor.authorTeixeira, Fabio Vieira [UNESP]
dc.contributor.authorRomiti, Ricardo
dc.contributor.institutionHosp Israelita Albert Einstein
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-20T13:32:37Z
dc.date.available2014-05-20T13:32:37Z
dc.date.issued2012-06-01
dc.description.abstractAlthough therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon. (C) 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.en
dc.description.affiliationHosp Israelita Albert Einstein, Unit Inflammatory Bowel Dis, BR-05652900 São Paulo, Brazil
dc.description.affiliationUniv State São Paulo UNESP, Botucatu Med Sch, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil
dc.description.affiliationState Univ São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil
dc.description.affiliationUniv State São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil
dc.description.affiliationUniv São Paulo, Sch Med Sci, Dept Dermatol, São Paulo, Brazil
dc.description.affiliationUnespUniv State São Paulo UNESP, Botucatu Med Sch, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil
dc.description.affiliationUnespState Univ São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil
dc.description.affiliationUnespUniv State São Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, Botucatu, SP, Brazil
dc.format.extent610-616
dc.identifierhttp://dx.doi.org/10.1016/j.crohns.2011.12.007
dc.identifier.citationJournal of Crohns & Colitis. Amsterdam: Elsevier B.V., v. 6, n. 5, p. 610-616, 2012.
dc.identifier.doi10.1016/j.crohns.2011.12.007
dc.identifier.issn1873-9946
dc.identifier.urihttp://hdl.handle.net/11449/11130
dc.identifier.wosWOS:000304689700016
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Crohns & Colitis
dc.relation.ispartofjcr6.637
dc.relation.ispartofsjr2,728
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectBiological therapyen
dc.subjectCrohn's diseaseen
dc.subjectInfliximaben
dc.subjectPsoriasisen
dc.subjectTumor necrosis factor-alpha inhibitorsen
dc.titleInfliximab-induced psoriasis during therapy for Crohn's diseaseen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
unesp.author.orcid0000-0003-0525-3480[2]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentCirurgia e Ortopedia - FMBpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 2 de 2
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: